PP_1170x120_10-25-21

0.15 mg

Teva announces availability of a generic equivalent of EpiPen Jr.

Teva announces availability of a generic equivalent of EpiPen Jr.

PARSIPPANY, N.J. — Teva Pharmaceutical announced availability of the FDA-approved generic version of EpiPen Jr (epinephrine injection, USP) Auto-Injector, 0.15 mg, in the U.S. The product is available in most retail pharmacies, and the wholesale acquisition cost is $300 for a 2-pack. “We’re pleased to provide access to Epinephrine Injection (Auto-Injector) in two strengths for

Adheris Health